Lineage Announces Formation of Scientific Advisory Board Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced…
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today highlighted…
AdaptHealth Refinances Credit Facility, Extends Maturity and Lowers Debt Costs AdaptHealth Corp., a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced…
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria Enanta Pharmaceuticals, Inc., a clinical-stage…
U.S. Grants Priority Review to Ifinatamab Deruxtecan for Previously Treated ES-SCLC Patients After Platinum Therapy Daiichi Sankyo and Merck & Co. have reached an important regulatory milestone with the U.S.…
Johnson & Johnson Presents New TECNIS PureSee IOL Clinical Data Showing Strong Contrast Sensitivity and Extended Vision Range at ASCRS 2026 Johnson & Johnson (NYSE: JNJ) has announced the presentation…
Prothena Corporation plc Reports Updates to Its Leadership Team Prothena Corporation plc (NASDAQ: PRTA), a late-stage biotechnology company focused on developing therapies for diseases driven by protein dysregulation, has announced…
Covalon Technologies Ltd. Highlights Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting Covalon Technologies Ltd., a company specializing in advanced medical technologies for wound care…
FairJourney Biologics Launches Cryo-EM Structural Biology Facility in San Diego FairJourney Bio (FJBio), a global contract research organization specializing in antibody discovery, has announced the opening of a cutting-edge cryo-electron…
Verastem Oncology Presents Two-Year Median Follow-Up Data for AVMAPKI®–FAKZYNJA® Combination in Recurrent Low-Grade Serous Ovarian Cancer at SGO 2026 Annual Meeting on Women’s Cancers Verastem Oncology (Nasdaq: VSTM), a company…
Bial Introduces Awareness and Education Initiative in Support of World Parkinson’s Day Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, has announced the launch of a major…
Ossium Health Welcomes Indiana Governor Mike Braun and Healthcare Leaders for Facility Tour and Reception Ossium Health recently opened its doors to state officials, healthcare leaders, and members of the…